04/30/2025 3:40 PM | Akoya Biosciences (Subject) Quanterix Corp (Filed by)
| Form SCHEDULE 13D/A | |
04/29/2025 4:15 PM | Akoya Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/29/2025 4:17 PM | Akoya Biosciences (Subject)
| Form 425 | |
04/29/2025 8:12 AM | Akoya Biosciences (Subject) Quanterix Corp (Filed by)
| Form 425 | |
04/28/2025 5:03 AM | Akoya Biosciences (Filer)
| Form 10-K/A | |
04/04/2025 7:30 AM | Akoya Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/04/2025 7:31 AM | Akoya Biosciences (Subject)
| Form 425 | |
04/04/2025 5:11 AM | Akoya Biosciences (Subject) Quanterix Corp (Filed by)
| Form 425 | |
04/03/2025 4:14 PM | Akoya Biosciences (Issuer) Ek John Frederick (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/25/2025 5:32 PM | Akoya Biosciences (Issuer) Ramachandran Niro Ph.D (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/25/2025 5:34 PM | Akoya Biosciences (Issuer) McKelligon Brian (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for AKYA and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Akoya Biosciences and its competitors with MarketBeat's FREE daily newsletter.
|
03/18/2025 11:36 AM | Akoya Biosciences (Subject) Quanterix Corp (Filed by)
| Form 425 | |
03/17/2025 3:25 PM | Akoya Biosciences (Subject) Quanterix Corp (Filed by)
| Form 425 | |
03/17/2025 3:15 PM | Akoya Biosciences (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/04/2025 4:16 PM | Akoya Biosciences (Issuer) Kamocsay Jennifer (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/03/2025 3:17 PM | Akoya Biosciences (Subject) Quanterix Corp (Filed by)
| Form 425 | |
02/25/2025 4:15 PM | Akoya Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/25/2025 4:16 PM | Akoya Biosciences (Subject)
| Form 425 | |
02/25/2025 4:22 PM | Akoya Biosciences (Subject) Quanterix Corp (Filed by)
| Form 425 | |
02/11/2025 3:37 PM | Akoya Biosciences (Subject) Quanterix Corp (Filed by)
| Form 425 | |
01/16/2025 8:29 PM | Akoya Biosciences (Filed by) Quanterix Corp (Subject)
| Form SCHEDULE 13D | |
01/16/2025 5:00 PM | Akoya Biosciences (Subject) Quanterix Corp (Filed by)
| Form SCHEDULE 13D | |
01/16/2025 8:25 AM | Akoya Biosciences (Subject)
| Form 425 | |
01/15/2025 8:04 PM | Akoya Biosciences (Subject) Quanterix Corp (Filed by)
| Form 425 | |
01/14/2025 6:03 AM | Akoya Biosciences (Subject) Quanterix Corp (Filed by)
| Form 425 | |
01/10/2025 3:46 PM | Akoya Biosciences (Subject) Quanterix Corp (Filed by)
| Form 425 | |
01/10/2025 3:24 PM | Akoya Biosciences (Subject)
| Form 425 | |
01/10/2025 7:31 AM | Akoya Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/10/2025 7:32 AM | Akoya Biosciences (Subject)
| Form 425 | |
01/10/2025 7:02 AM | Akoya Biosciences (Subject) Quanterix Corp (Filed by)
| Form 425 | |
12/13/2024 4:18 PM | Akoya Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/21/2024 4:18 PM | Akoya Biosciences (Issuer) McKelligon Brian (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/21/2024 4:19 PM | Akoya Biosciences (Issuer) Ramachandran Niro Ph.D (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/21/2024 4:20 PM | Akoya Biosciences (Issuer) BAMFORD PASCAL (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/21/2024 4:21 PM | Akoya Biosciences (Issuer) Ek John Frederick (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/21/2024 4:22 PM | Akoya Biosciences (Issuer) Kamocsay Jennifer (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/04/2024 6:39 AM | Akoya Biosciences (Subject) Schindel Yair Chaim (Filed by)
| Form SC 13G/A | |
10/04/2024 5:44 PM | Akoya Biosciences (Issuer) Mendel Scott (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/03/2024 8:40 PM | Akoya Biosciences (Issuer) BAMFORD PASCAL (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
09/03/2024 8:41 PM | Akoya Biosciences (Issuer) BAMFORD PASCAL (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/28/2024 9:45 AM | Akoya Biosciences (Subject) Blue Water Life Science Advisors, LP (Filed by)
| Form SC 13G | |
Gold Alert: The Truth About Fort Knox Is Coming (Ad) Owning physical gold isn’t the best way to profit.
I’ve found a better way to invest in gold—one that’s already performing nearly twice as well as gold this year and looks ready to go much higher.
If you wait for the news to hit, you’ll already be too late. Click here now before the biggest gold run in decades kicks off. |
06/11/2024 3:36 PM | Akoya Biosciences (Subject) McKelligon Brian (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/07/2024 8:56 PM | Akoya Biosciences (Issuer) McKelligon Brian (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/05/2024 4:53 PM | Akoya Biosciences (Issuer) Mendel Scott (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/05/2024 4:54 PM | Akoya Biosciences (Issuer) LAI GOLDMAN MYLA (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/05/2024 4:55 PM | Akoya Biosciences (Issuer) SCHNETTLER THOMAS P (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/05/2024 4:56 PM | Akoya Biosciences (Issuer) Winkler Matthew (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/05/2024 4:57 PM | Akoya Biosciences (Issuer) SHEPLER ROBERT G (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/05/2024 4:58 PM | Akoya Biosciences (Issuer) Raffin Thomas A. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |